skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 121,351  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Oncology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prädiktion der pathologischen Komplettremission beim Ösophaguskarzinom nach neoadjuvanter Radiochemotherapie mittels FDG-PET/CT und diffusionsgewichteter MRT
Material Type:
Article
Add to My Research

Prädiktion der pathologischen Komplettremission beim Ösophaguskarzinom nach neoadjuvanter Radiochemotherapie mittels FDG-PET/CT und diffusionsgewichteter MRT

Strahlentherapie und Onkologie, 2021-09, Vol.197 (9), p.862-864 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/deed.de (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0179-7158 ;EISSN: 1439-099X ;DOI: 10.1007/s00066-021-01813-1

Full text available

2
Anemia--still a major health problem in many parts of the world
Material Type:
Article
Add to My Research

Anemia--still a major health problem in many parts of the world

Annals of hematology, 2011-04, Vol.90 (4), p.369-377 [Peer Reviewed Journal]

Springer-Verlag 2011 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0939-5555 ;EISSN: 1432-0584 ;DOI: 10.1007/s00277-010-1144-5 ;PMID: 21221586

Full text available

3
Evaluation of data-driven respiratory gating waveforms for clinical PET imaging
Material Type:
Article
Add to My Research

Evaluation of data-driven respiratory gating waveforms for clinical PET imaging

EJNMMI research, 2019-01, Vol.9 (1), p.1-10, Article 1 [Peer Reviewed Journal]

The Author(s). 2019 ;EJNMMI Research is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2191-219X ;EISSN: 2191-219X ;DOI: 10.1186/s13550-018-0470-9 ;PMID: 30607651

Full text available

4
Prävention der Exazerbation bei COPD: Rolle einer Dauertherapie mit Azithromycin
Material Type:
Article
Add to My Research

Prävention der Exazerbation bei COPD: Rolle einer Dauertherapie mit Azithromycin

Pneumologe, 2012, Vol.9 (4), p.285-286

Springer-Verlag 2012 ;ISSN: 1613-5636 ;EISSN: 1613-6055 ;DOI: 10.1007/s10405-012-0577-z

Full text available

5
Mortalitätsrisiko bei Patienten mit peptischer Ulkusblutung: Ergebnisse einer Kohortenstudie mit über 10.000 Patienten
Material Type:
Article
Add to My Research

Mortalitätsrisiko bei Patienten mit peptischer Ulkusblutung: Ergebnisse einer Kohortenstudie mit über 10.000 Patienten

Gastroenterologe, 2010, Vol.5 (2), p.138-140

Springer Medizin Verlag 2010 ;ISSN: 1861-9681 ;EISSN: 1861-969X ;DOI: 10.1007/s11377-010-0406-z

Full text available

6
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
Material Type:
Article
Add to My Research

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

Breast cancer research and treatment, 2023-07, Vol.200 (1), p.73-73 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2023 ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-023-06928-w

Digital Resources/Online E-Resources

7
Correction to: Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling
Material Type:
Article
Add to My Research

Correction to: Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling

Breast cancer research and treatment, 2023-06, Vol.199 (3), p.627-629 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2023 ;Springer Science+Business Media, LLC, part of Springer Nature 2023. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-023-06939-7 ;PMID: 37079214

Full text available

8
GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists
Material Type:
Article
Add to My Research

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6497-6500 [Peer Reviewed Journal]

Society of Surgical Oncology 2022 ;Society of Surgical Oncology 2022. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-022-12151-6

Full text available

9
Correction to: Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research
Material Type:
Article
Add to My Research

Correction to: Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research

Breast cancer research and treatment, 2022-04, Vol.192 (2), p.245-247 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2022 ;Springer Science+Business Media, LLC, part of Springer Nature 2022. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-022-06534-2 ;PMID: 35133550

Full text available

10
Japanese gastric cancer treatment guidelines 2018 (5th edition)
Material Type:
Article
Add to My Research

Japanese gastric cancer treatment guidelines 2018 (5th edition)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-01, Vol.24 (1), p.1-21 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 1436-3291 ;EISSN: 1436-3305 ;DOI: 10.1007/s10120-020-01042-y

Digital Resources/Online E-Resources

11
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D)
Material Type:
Article
Add to My Research

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D)

Breast cancer research and treatment, 2022, Vol.191 (1), p.225-225 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2021 ;Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06409-y ;PMID: 34625860

Full text available

12
Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations
Material Type:
Article
Add to My Research

Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations

Breast cancer research and treatment, 2022, Vol.191 (1), p.221-221 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2021 ;Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06380-8 ;PMID: 34606001

Full text available

13
Correction: Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery
Material Type:
Article
Add to My Research

Correction: Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery

Annals of surgical oncology, 2024-06, Vol.31 (6), p.3956-3956 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-024-15212-0

Digital Resources/Online E-Resources

14
Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry
Material Type:
Article
Add to My Research

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.305-305 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2021 ;Springer Science+Business Media, LLC, part of Springer Nature 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06268-7 ;PMID: 34231078

Full text available

15
Correction to: Postmastectomy Functional Impairments
Material Type:
Article
Add to My Research

Correction to: Postmastectomy Functional Impairments

Current oncology reports, 2023-12, Vol.25 (12), p.1455-1455 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 1523-3790 ;EISSN: 1534-6269 ;DOI: 10.1007/s11912-023-01481-7

Digital Resources/Online E-Resources

16
AJCC 8th Edition: Colorectal Cancer
Material Type:
Article
Add to My Research

AJCC 8th Edition: Colorectal Cancer

Annals of surgical oncology, 2018-06, Vol.25 (6), p.1454-1455 [Peer Reviewed Journal]

Society of Surgical Oncology 2018 ;Annals of Surgical Oncology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-018-6462-1 ;PMID: 29616422

Full text available

17
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
Material Type:
Article
Add to My Research

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7873-7888 [Peer Reviewed Journal]

Society of Surgical Oncology 2021 ;Society of Surgical Oncology 2021. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-021-09654-z ;PMID: 33852100

Full text available

18
Correction to: Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity
Material Type:
Article
Add to My Research

Correction to: Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity

Current oncology reports, 2023-10, Vol.25 (10), p.1095-1095 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 1523-3790 ;EISSN: 1534-6269 ;DOI: 10.1007/s11912-023-01456-8

Digital Resources/Online E-Resources

19
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
Material Type:
Article
Add to My Research

8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers

Annals of surgical oncology, 2018-04, Vol.25 (4), p.845-847 [Peer Reviewed Journal]

Society of Surgical Oncology 2017 ;Annals of Surgical Oncology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-017-6025-x ;PMID: 28752469

Full text available

20
Correction to: Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma
Material Type:
Article
Add to My Research

Correction to: Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma

Journal of neuro-oncology, 2024-06, Vol.168 (2), p.237-238 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0167-594X ;EISSN: 1573-7373 ;DOI: 10.1007/s11060-024-04701-7

Digital Resources/Online E-Resources

Results 1 - 20 of 121,351  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (118,902)

Refine My Results

Creation Date 

From To
  1. Before 1997  (6)
  2. 1997 To 2003  (10)
  3. 2004 To 2010  (17,668)
  4. 2011 To 2017  (52,217)
  5. After 2017  (51,494)
  6. More options open sub menu

Resource Type 

  1. Articles  (121,132)
  2. Reviews  (118)
  3. Books  (101)
  4. More options open sub menu

Subject 

  1. Medicine & Public Health  (121,349)
  2. Medicine  (121,170)
  3. Life Sciences & Biomedicine  (102,487)
  4. Science & Technology  (102,487)
  5. Humans  (79,357)
  6. Female  (49,350)
  7. Male  (39,518)
  8. Original Article  (37,762)
  9. Middle Aged  (36,143)
  10. Aged  (29,784)
  11. Adult  (27,644)
  12. Hematology  (24,800)
  13. Cancer Research  (23,932)
  14. Surgical Oncology  (22,279)
  15. Surgery  (21,094)
  16. Cancer  (18,610)
  17. Internal Medicine  (16,282)
  18. Tumors  (16,182)
  19. Prognosis  (15,495)
  20. More options open sub menu

Language 

  1. English  (114,508)
  2. Japanese  (12,796)
  3. German  (5,352)
  4. French  (1,568)
  5. Norwegian  (90)
  6. Russian  (17)
  7. Dutch  (3)
  8. Korean  (2)
  9. More options open sub menu

Searching Remote Databases, Please Wait